{
  "main_header": {
    "sid": 734514,
    "name": "Dr Reddy's Labs",
    "stock_name": "Dr Reddy's Labs",
    "full_name": "Dr Reddys Laboratories Ltd",
    "name_url": "stocks-analysis/dr-reddy-s-labs",
    "exchange": 1,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "1,278.20",
    "chg": -1.8,
    "chgp": "-0.14%",
    "dir": -1,
    "prev_price": "1,280.00",
    "mcapval": "107,480.00 Cr",
    "mcap": "Large Cap",
    "scripcode": "500124",
    "symbol": "DRREDDY",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE089A01031",
    "curr_date": "Dec 19",
    "curr_time": "",
    "bse_nse_vol": "12.21 lacs",
    "exc_status": "Active",
    "traded_date": "Dec 19, 2025",
    "traded_date_str": "2025 12 19",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/dr-reddy-s-labs-734514-1&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Dr Reddys Laboratories: Navigating Market Dynamics as a Nifty 50 Constituent",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/dr-reddys-laboratories-navigating-nifty-50-membership-amid-mixed-performance-3763490",
        "imagepath": "",
        "date": "2025-12-19 09:21:04",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <p><strong>Significance of Nifty 50 Membership</strong></p>\n                <p>Being part of the Nifty 50 index places Dr Reddys Laboratories among the top 50 large-cap companies listed on the National Stock Exchange of India, reflecting its substantial market capitalisation and liquidity. This membership not only enhances the stock’s visibility but also ensures its inclusion in numerous index-tracking funds and institutional portfolios. Consequently, the stock experiences consistent trading volumes and heightened investor attention, factors that contribute to its market stability and valuation dynamics.</p>\n\n                <p>Dr Reddys Laboratories currently holds a market capitalisation of approximately ₹1,06,799 crores, categorising it firmly within the large-cap segment. This scale ..."
      },
      {
        "title": "Dr Reddys Laboratories: Navigating Nifty 50 Membership Amid Sector and Market Dynamics",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/dr-reddys-laboratories-navigating-nifty-50-membership-amid-mixed-performance-and-institutional-shifts-3762100",
        "imagepath": "",
        "date": "2025-12-18 09:21:04",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <p><strong>Significance of Nifty 50 Membership</strong></p>\n                <p>Being part of the Nifty 50 index places Dr Reddys Laboratories among the most influential and widely tracked companies on the National Stock Exchange of India. This membership not only enhances the stock’s visibility among institutional investors but also ensures its inclusion in numerous index-linked investment products such as exchange-traded funds (ETFs) and mutual funds. Consequently, the stock’s liquidity and trading volumes are typically robust, providing a stable platform for investor participation.</p>\n                <p>Index inclusion also means that Dr Reddys Laboratories is subject to periodic reviews based on market capitalisation and free-float criteria, which can influence institutional holding ..."
      },
      {
        "title": "Dr Reddys Laboratories: Navigating Market Dynamics as a Nifty 50 Constituent",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/dr-reddys-laboratories-navigating-nifty-50-membership-amid-mixed-performance-and-institutional-shifts-3760906",
        "imagepath": "",
        "date": "2025-12-17 09:21:21",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <p><strong>Significance of Nifty 50 Membership</strong></p>\n                <p>Being a constituent of the Nifty 50 index places Dr Reddys Laboratories among the most influential and liquid stocks on the National Stock Exchange of India. This membership not only underscores the company’s market capitalisation and trading volumes but also ensures its inclusion in numerous index-tracking funds and institutional portfolios. Consequently, the stock’s price movements often mirror broader market sentiment and sectoral developments, making it a bellwether for the Pharmaceuticals & Biotechnology industry.</p>\n                <p>Dr Reddys Laboratories, with a market capitalisation of approximately ₹1,05,964.67 crores, stands as a large-cap entity within the sector. Its presence in the index contri..."
      },
      {
        "title": "Dr Reddys Laboratories: Navigating Market Dynamics as a Nifty 50 Constituent",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/dr-reddys-laboratories-navigating-nifty-50-membership-amid-mixed-performance-and-institutional-shifts-3759767",
        "imagepath": "",
        "date": "2025-12-16 09:20:49",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <p><strong>Significance of Nifty 50 Membership</strong></p>\n                <p>Being part of the Nifty 50 index, Dr Reddys Laboratories benefits from enhanced visibility and liquidity, attracting institutional investors and index funds that replicate the benchmark. This membership often results in increased trading volumes and a degree of price stability, as the stock forms a core component of India’s equity market barometer. The company’s market capitalisation stands at approximately ₹1,06,478 crores, categorising it firmly within the large-cap segment, which is a critical factor for index inclusion.</p>\n                <p>Dr Reddys Laboratories’ presence in the index also reflects its role as a bellwether for the Pharmaceuticals & Biotechnology sector, which is currently navigating a m..."
      },
      {
        "title": "Dr Reddys Laboratories: Navigating Nifty 50 Membership and Market Dynamics",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/dr-reddys-laboratories-navigating-nifty-50-membership-amid-mixed-market-performance-3758438",
        "imagepath": "",
        "date": "2025-12-15 09:21:00",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <p><strong>Significance of Nifty 50 Membership</strong></p>\n                <p>Being part of the Nifty 50 index places Dr Reddys Laboratories in a select group of companies that represent the largest and most liquid stocks on the National Stock Exchange of India. This membership not only enhances the stock’s visibility among domestic and international investors but also ensures its inclusion in numerous index-tracking funds and exchange-traded funds (ETFs). Consequently, the stock benefits from steady demand driven by passive investment flows, which can influence price stability and liquidity.</p>\n                <p>Dr Reddys Laboratories’ market capitalisation stands at approximately ₹1,05,818.61 crores, categorising it firmly as a large-cap stock. This scale supports its role as a benc..."
      },
      {
        "title": "Dr Reddys Laboratories: Navigating Nifty 50 Membership and Market Dynamics",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/dr-reddys-laboratories-navigating-nifty-50-membership-and-institutional-shifts-3757172",
        "imagepath": "",
        "date": "2025-12-12 09:21:10",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <p><strong>Significance of Nifty 50 Membership</strong></p>\n                <p>Being a constituent of the Nifty 50 index places Dr Reddys Laboratories among the elite group of companies that represent the Indian equity market’s broad performance. This membership not only enhances the stock’s visibility among domestic and international investors but also influences trading volumes and liquidity. Index funds and exchange-traded funds (ETFs) tracking the Nifty 50 are mandated to hold shares of Dr Reddys Laboratories, thereby embedding the stock deeply within passive investment strategies.</p>\n                <p>The company’s market capitalisation stands at ₹1,06,244 crores, categorising it firmly as a large-cap entity. This scale supports its inclusion in the benchmark index, which is desig..."
      },
      {
        "title": "Dr Reddys Laboratories: Navigating Nifty 50 Membership and Market Dynamics",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/dr-reddys-laboratories-navigating-nifty-50-membership-and-institutional-shifts-amid-sector-challenges-3756091",
        "imagepath": "",
        "date": "2025-12-11 09:20:51",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <p><strong>Index Membership and Market Capitalisation</strong></p>\n                <p>As a large-cap stock with a market capitalisation of approximately ₹1,04,662.65 crores, Dr Reddys Laboratories maintains a pivotal role within the Nifty 50, India's premier benchmark index. This membership not only enhances the stock's visibility among institutional investors but also ensures its inclusion in various index-linked investment products such as exchange-traded funds (ETFs) and mutual funds. The company's presence in the index signals its relative stability and market influence within the Pharmaceuticals & Biotechnology sector.</p>\n                <p>Dr Reddys Laboratories' price-to-earnings (P/E) ratio stands at 18.07, notably below the sector average of 33.47. This differential suggests a ..."
      },
      {
        "title": "Dr Reddys Laboratories: Navigating Market Dynamics as a Nifty 50 Constituent",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/dr-reddys-laboratories-navigating-nifty-50-membership-amid-mixed-performance-and-institutional-shifts-3754924",
        "imagepath": "",
        "date": "2025-12-10 09:20:48",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <p><strong>Significance of Nifty 50 Membership</strong></p>\n                <p>Being part of the Nifty 50 index places Dr Reddys Laboratories among the most influential and widely tracked stocks on the National Stock Exchange of India. This membership not only enhances the stock’s visibility but also ensures its inclusion in numerous index-linked investment products such as exchange-traded funds (ETFs) and mutual funds. Consequently, the stock benefits from steady institutional interest and liquidity, factors that are crucial for large-cap companies operating in competitive sectors like Pharmaceuticals & Biotechnology.</p>\n                <p>Dr Reddys Laboratories, with a market capitalisation of approximately ₹1,04,327.65 crores, stands as a heavyweight within its sector. Its presence i..."
      },
      {
        "title": "Dr Reddys Laboratories: Navigating Nifty 50 Membership Amid Sector and Market Dynamics",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/dr-reddys-laboratories-navigating-nifty-50-membership-amid-mixed-performance-and-institutional-shifts-3753139",
        "imagepath": "",
        "date": "2025-12-09 09:20:46",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <p><strong>Significance of Nifty 50 Membership</strong></p>\n                <p>Being part of the Nifty 50 index places Dr Reddys Laboratories among the top-tier companies that shape the Indian equity market’s performance. This membership not only enhances the stock’s visibility among institutional investors but also influences trading volumes and liquidity. The company’s market capitalisation stands at approximately ₹1,05,245.73 crores, categorising it firmly as a large-cap stock. This scale supports its inclusion in the benchmark index, which is designed to represent the broader market’s health and direction.</p>\n\n                <p>Index membership often attracts passive fund flows from exchange-traded funds (ETFs) and index funds tracking the Nifty 50, thereby impacting demand dynamic..."
      }
    ],
    "total": 423,
    "sid": "734514",
    "stock_news_url": "https://www.marketsmojo.com/news/dr-reddys-laboratories-734514"
  },
  "announcements": [
    {
      "details": "Dr. Reddy's Laboratories Limited has submitted to the Exchange a copy of Disclosure of Related Party Transactions for the period ended September 30, 2019.",
      "source": "NSE",
      "caption": "Dr. Reddy's Laboratories Limited - Other General Purpose",
      "datetime": "28-Nov-2019"
    },
    {
      "details": "Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated November 22, 2019, titled \"Dr. Reddy's Laboratories announces launch of",
      "source": "NSE",
      "caption": "Dr. Reddy's Laboratories Limited - Press Release",
      "datetime": "22-Nov-2019"
    },
    {
      "details": "Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated November 14, 2019, titled \"Dr. Reddy s Laboratories enters Nutrition Segment with Celevida in India.\".",
      "source": "NSE",
      "caption": "Dr. Reddy's Laboratories Limited - Press Release",
      "datetime": "14-Nov-2019"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Dr Reddys Laboratories Ltd has declared <strong>800%</strong> dividend, ex-date: 10 Jul 25",
          "dt": "2025-07-10",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Dr Reddys Laboratories Ltd has announced <strong>1:5</strong> stock split, ex-date: 28 Oct 24",
          "dt": "2024-10-28",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Dr Reddys Laboratories Ltd has announced <strong>1:1</strong> bonus issue, ex-date: 28 Aug 06",
          "dt": "2006-08-28",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Dr Reddys Laboratories: Navigating Market Dynamics as a Nifty 50 Constituent

2025-12-19 09:21:04

Significance of Nifty 50 Membership

Being part of the Nifty 50 index places Dr Reddys Laboratories among the top 50 large-cap companies listed on the National Stock Exchange of India, reflecting its substantial market capitalisation and liquidity. This membership not only enhances the stock’s visibility but also ensures its inclusion in numerous index-tracking funds and institutional portfolios. Consequently, the stock experiences consistent trading volumes and heightened investor attention, factors that contribute to its market stability and valuation dynamics.

Dr Reddys Laboratories currently holds a market capitalisation of approximately ₹1,06,799 crores, categorising it firmly within the large-cap segment. This scale ...

Read More

Dr Reddys Laboratories: Navigating Nifty 50 Membership Amid Sector and Market Dynamics

2025-12-18 09:21:04

Significance of Nifty 50 Membership

Being part of the Nifty 50 index places Dr Reddys Laboratories among the most influential and widely tracked companies on the National Stock Exchange of India. This membership not only enhances the stock’s visibility among institutional investors but also ensures its inclusion in numerous index-linked investment products such as exchange-traded funds (ETFs) and mutual funds. Consequently, the stock’s liquidity and trading volumes are typically robust, providing a stable platform for investor participation.

Index inclusion also means that Dr Reddys Laboratories is subject to periodic reviews based on market capitalisation and free-float criteria, which can influence institutional holding ...

Read More

Dr Reddys Laboratories: Navigating Market Dynamics as a Nifty 50 Constituent

2025-12-17 09:21:21

Significance of Nifty 50 Membership

Being a constituent of the Nifty 50 index places Dr Reddys Laboratories among the most influential and liquid stocks on the National Stock Exchange of India. This membership not only underscores the company’s market capitalisation and trading volumes but also ensures its inclusion in numerous index-tracking funds and institutional portfolios. Consequently, the stock’s price movements often mirror broader market sentiment and sectoral developments, making it a bellwether for the Pharmaceuticals & Biotechnology industry.

Dr Reddys Laboratories, with a market capitalisation of approximately ₹1,05,964.67 crores, stands as a large-cap entity within the sector. Its presence in the index contri...

Read More

Dr Reddys Laboratories: Navigating Market Dynamics as a Nifty 50 Constituent

2025-12-16 09:20:49

Significance of Nifty 50 Membership

Being part of the Nifty 50 index, Dr Reddys Laboratories benefits from enhanced visibility and liquidity, attracting institutional investors and index funds that replicate the benchmark. This membership often results in increased trading volumes and a degree of price stability, as the stock forms a core component of India’s equity market barometer. The company’s market capitalisation stands at approximately ₹1,06,478 crores, categorising it firmly within the large-cap segment, which is a critical factor for index inclusion.

Dr Reddys Laboratories’ presence in the index also reflects its role as a bellwether for the Pharmaceuticals & Biotechnology sector, which is currently navigating a m...

Read More

Dr Reddys Laboratories: Navigating Nifty 50 Membership and Market Dynamics

2025-12-15 09:21:00

Significance of Nifty 50 Membership

Being part of the Nifty 50 index places Dr Reddys Laboratories in a select group of companies that represent the largest and most liquid stocks on the National Stock Exchange of India. This membership not only enhances the stock’s visibility among domestic and international investors but also ensures its inclusion in numerous index-tracking funds and exchange-traded funds (ETFs). Consequently, the stock benefits from steady demand driven by passive investment flows, which can influence price stability and liquidity.

Dr Reddys Laboratories’ market capitalisation stands at approximately ₹1,05,818.61 crores, categorising it firmly as a large-cap stock. This scale supports its role as a benc...

Read More

Dr Reddys Laboratories: Navigating Nifty 50 Membership and Market Dynamics

2025-12-12 09:21:10

Significance of Nifty 50 Membership

Being a constituent of the Nifty 50 index places Dr Reddys Laboratories among the elite group of companies that represent the Indian equity market’s broad performance. This membership not only enhances the stock’s visibility among domestic and international investors but also influences trading volumes and liquidity. Index funds and exchange-traded funds (ETFs) tracking the Nifty 50 are mandated to hold shares of Dr Reddys Laboratories, thereby embedding the stock deeply within passive investment strategies.

The company’s market capitalisation stands at ₹1,06,244 crores, categorising it firmly as a large-cap entity. This scale supports its inclusion in the benchmark index, which is desig...

Read More

Dr Reddys Laboratories: Navigating Nifty 50 Membership and Market Dynamics

2025-12-11 09:20:51

Index Membership and Market Capitalisation

As a large-cap stock with a market capitalisation of approximately ₹1,04,662.65 crores, Dr Reddys Laboratories maintains a pivotal role within the Nifty 50, India's premier benchmark index. This membership not only enhances the stock's visibility among institutional investors but also ensures its inclusion in various index-linked investment products such as exchange-traded funds (ETFs) and mutual funds. The company's presence in the index signals its relative stability and market influence within the Pharmaceuticals & Biotechnology sector.

Dr Reddys Laboratories' price-to-earnings (P/E) ratio stands at 18.07, notably below the sector average of 33.47. This differential suggests a ...

Read More

Dr Reddys Laboratories: Navigating Market Dynamics as a Nifty 50 Constituent

2025-12-10 09:20:48

Significance of Nifty 50 Membership

Being part of the Nifty 50 index places Dr Reddys Laboratories among the most influential and widely tracked stocks on the National Stock Exchange of India. This membership not only enhances the stock’s visibility but also ensures its inclusion in numerous index-linked investment products such as exchange-traded funds (ETFs) and mutual funds. Consequently, the stock benefits from steady institutional interest and liquidity, factors that are crucial for large-cap companies operating in competitive sectors like Pharmaceuticals & Biotechnology.

Dr Reddys Laboratories, with a market capitalisation of approximately ₹1,04,327.65 crores, stands as a heavyweight within its sector. Its presence i...

Read More

Dr Reddys Laboratories: Navigating Nifty 50 Membership Amid Sector and Market Dynamics

2025-12-09 09:20:46

Significance of Nifty 50 Membership

Being part of the Nifty 50 index places Dr Reddys Laboratories among the top-tier companies that shape the Indian equity market’s performance. This membership not only enhances the stock’s visibility among institutional investors but also influences trading volumes and liquidity. The company’s market capitalisation stands at approximately ₹1,05,245.73 crores, categorising it firmly as a large-cap stock. This scale supports its inclusion in the benchmark index, which is designed to represent the broader market’s health and direction.

Index membership often attracts passive fund flows from exchange-traded funds (ETFs) and index funds tracking the Nifty 50, thereby impacting demand dynamic...

Read More

View All News